Skip to main content
Log in

Parenteral methotrexate in Crohn's disease: clinical benefits at low cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Mlcoch T, et al. Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn's Disease. Applied Health Economics and Health Policy : 11 Jan 2021. Available from: URL: https://doi.org/10.1007/s40258-020-00628-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parenteral methotrexate in Crohn's disease: clinical benefits at low cost. PharmacoEcon Outcomes News 870, 21 (2021). https://doi.org/10.1007/s40274-021-7424-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7424-6

Navigation